Medgenics, Inc. (NYSE: MDGN) announced the pricing of 3,640,000 shares of its common stock in a previously announced underwritten public ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE